Skip to main content

Table 1 Demographic and baseline characteristics of patients with DR-TB treated with IFN gamma

From: Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

Patient

1

2

3

4

5

6

7

8

Age (years)

28

50

54

27

44

50

23

37

Sex

Male

Male

Female

Female

Male

Male

Female

Male

Race

Mestizo

White

Mestizo

Mestizo

White

Mestizo

Black

Black

BMI (Kg/m 2 )

19.6

18.9

13.2

18.3

14.6

21.6

22.0

17.1

Sputum smear status*

0

9

9

9

8

9

8

9

Sputum culture status**

7

9

7

9

6

9

8

9

Drug Resistance

INH

RIF

STR

INH

STR

INH

RIF

STR

INH

RIF

INH, STR

INH

RIF

STR

INH

INH

Initial thorax X-ray

R1

R2

R3

R4

R5

R6

R7

R8

GSR (mm/h)

5

66

53

53

68

101

10

60

  1. INH: Isoniazid; RIF: Rifampin; STR: Streptomycin; ETB: Ethambutol; ETN: Ethionamide; PRZ: Pyrazinamide; CPF: Ciprofloxacin; KAN: Kanamycin; AMK: Amikacin.
  2. * Number of bacilli; 0: 0 in 4 lines; 8: 25 or more in 1 line; 9: bacilli in most of the fields.
  3. ** Number of colonies; 6: 6–24 colonies; 7: 25–100 colonies; 9: confluent growth.
  4. R1 and R3. Extensive bilateral exudative lesions
  5. R2: Moderate exudative lesions
  6. R4: Left fibro-exudative lesions
  7. R5: Moderate Bilateral fibro-exudative lesions.
  8. R6: Cavitary lesions at superior lobes; fibrous lesions at right superior lobe; alveolar infiltrate at left superior lobe.
  9. R7 and R8: Very diffuse fibromatous lesions at superior lobes.